CIGARETTE-SMOKE INCREASES BUPIVACAINE METABOLISM IN RATS

Citation
B. Bruguerolle et al., CIGARETTE-SMOKE INCREASES BUPIVACAINE METABOLISM IN RATS, Canadian journal of anaesthesia, 41(8), 1994, pp. 733-737
Citations number
11
Categorie Soggetti
Anesthesiology
ISSN journal
0832610X
Volume
41
Issue
8
Year of publication
1994
Pages
733 - 737
Database
ISI
SICI code
0832-610X(1994)41:8<733:CIBMIR>2.0.ZU;2-J
Abstract
This study was designed to document possible changes in bupivacaine ki netics in rats after exposure to cigarette smoke. Rats (n = 15) were e xposed to cigarette smoke (Borgwaldt type Hamburg II)for ten minutes p er day during four days (C) or eight days (B); controls (A) were used simultaneously without exposure to cigarette smoke. After bupivacaine 20 mg.kg(-1) ip at day 4 (C) or day 8 (B), blood was sampled (0.5 ml o f blood collected by puncture at the retro-orbital sinus 0.25, 0.5, 1, 2, 4, 6 and 8 hours after administration) and bupivacaine and its mai n metabolite i.e., desbutylbupivacaine (PPX) were determined by gas li quid chromatography. The sensitivity of the method was 15 ng.ml(-1) an d the reproductibility was <6%. Serum bupivacaine concentrations were plotted against time and the pharmacokinetic variables were determined assuming a two compartment open model: Cmax, Tmax were derived direct ly from individual data. The beta phase elimination half-lives (T(1/2) beta), the area under the serum concentration curve (AUC(0)(infinity)) , the total plasma clearance (CI) and the total volume of distribution (Vd) were calculated. These variables were assessed according to non- linear fitting method. Cigarette smoking exposure did not change the p harmacokinetic variables of bupivacaine. However the pharmacokinetic p arameters of PPX, Cmax (0.175 +/- 0.007 mu g.ml(-1), 0.119 +/- 0.014 m u g.ml(-1) and 0.312 +/- 0.023 mu g.ml(-1), for groups A, B and C, res pectively), AUC (0.170 +/- 0.006 mu g.ml(-1).hr(-1), 0.104 +/- 0.013 m u g.ml(-1.)hr(-1) and 0.433 +/- 0.017 mu g.ml(-1.)hr(-1) for groups A, B and C, respectively) and the ratio AUC PPX/ AUC bupivacaine (0.306 +/- 0.042, 0.153 +/- 0.021 and 0.660 +/- 0.054 for groups A, B and C, respectively were higher (P < 0.0001) for group C. These results indic ate an enzymatic induction after only short exposure to cigarette smok ing and justify further studies to document possible variations of the metabolism of bupivacaine induced by exposure to cigarette smoke in h umans.